4//SEC Filing
ATRIX LABORATORIES INC 4
Accession 0001212655-04-000009
CIK 0000809875operating
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 12:09 PM ET
Size
9.1 KB
Accession
0001212655-04-000009
Insider Transaction Report
Form 4
BETHUNE DAVID R
DirectorCEO/Chairman
Transactions
- Sale
Common Stock, $.001 Par Value
2004-11-05$31.01/sh−10,000$310,100→ 146,477 total - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-11-05$9.75/sh−10,000$97,500→ 60,000 totalExercise: $9.75From: 2001-06-02Exp: 2010-06-02→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock, $.001 Par Value
2004-11-05$9.75/sh+10,000$97,500→ 156,477 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000809875
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 12:09 PM ET
- Size
- 9.1 KB